Ledger.Open graph →
SEC Form D · filed December 15, 2016

Enumeral Biomedical Holdings, Inc

Offering
$10.8M
Sold
$3.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Kevin G. Sarney · Cambridge, MAExecPaul J. Sekhri · Cambridge, MADirectorRobert J. Easton · Cambridge, MADirectorBarry G. Buckland, Ph.D · Cambridge, MADirectorRobert L. Van Nostrand · Cambridge, MADirectorAllan P. Rothstein · Cambridge, MADirectorWael Fayad · Cambridge, MAExec · DirectorDonald O. Taylor · Knoxville, TNDirectorShahab B. Rashid · Chicago, ILDirectorKevin A. Phillip · Grand Cayman, Cayman IslandsDirectorTodd R. Daviau · CLEARWATER, FLDirectorMichael Plunkett · Carlsbad, CADirectorArmiger Capital, LLC · Nokomis, FLExecJon Allen · Carlsbad, CADirectorBrian Snider · Carlsbad, CADirectorDonald I. Williams · Carlsbad, CADirectorMortimer Berkowitz Iii · Carlsbad, CAExecJason T. Brass · Minneapolis, MNDirectorJeremiah Lucey · Brooklyn, NYDirectorWael Fayad · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗